NASDAQ:NUTX Nutex Health (NUTX) Stock Price, News & Analysis → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free NUTX Stock Alerts $0.58 -0.03 (-4.92%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$0.57▼$0.6150-Day Range$0.53▼$1.3452-Week Range$0.50▼$8.25Volume95,656 shsAverage Volume216,392 shsMarket Capitalization$28.82 millionP/E RatioN/ADividend YieldN/APrice Target$15.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Nutex Health alerts: Email Address Nutex Health MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,488.0% Upside$15.00 Price TargetShort InterestHealthy1.15% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$47,804 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.87 out of 5 starsMedical Sector560th out of 905 stocksBusiness Services, Not Elsewhere Classified Industry74th out of 91 stocks 3.5 Analyst's Opinion Consensus RatingNutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNutex Health has received no research coverage in the past 90 days.Read more about Nutex Health's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.15% of the float of Nutex Health has been sold short.Short Interest Ratio / Days to CoverNutex Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutex Health has recently increased by 4.60%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldNutex Health does not currently pay a dividend.Dividend GrowthNutex Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NUTX. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Nutex Health this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $47,804.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders38.52% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.32% of the stock of Nutex Health is held by institutions.Read more about Nutex Health's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutex Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutex Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutex Health has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Nutex Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here. About Nutex Health Stock (NASDAQ:NUTX)Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.Read More NUTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUTX Stock News HeadlinesMay 31, 2024 | insidertrades.comNutex Health Inc. (NASDAQ:NUTX) CEO Thomas T. Vo Purchases 17,330 SharesMay 24, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.May 11, 2024 | finance.yahoo.comNutex Health, Inc. (NASDAQ:NUTX) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Reports First Quarter 2024 Financial ResultsMay 9, 2024 | investorplace.comNUTX Stock Earnings: Nutex Health Beats Revenue for Q1 2024May 8, 2024 | prnewswire.comNUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSMay 8, 2024 | markets.businessinsider.comNutex Health earnings preview: what to expectMay 7, 2024 | prnewswire.comNUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALLMay 6, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETINGApril 29, 2024 | prnewswire.comNUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCEApril 29, 2024 | prnewswire.comNUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCEApril 22, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORSApril 16, 2024 | prnewswire.comNutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1April 12, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Provides Corporate UpdateApril 12, 2024 | prnewswire.comNUTEX HEALTH PROVIDES CORPORATE UPDATEApril 8, 2024 | finance.yahoo.comNUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSINApril 5, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces 1-for-15 Reverse Stock SplitApril 5, 2024 | investorplace.comWhy Is Nutex Health (NUTX) Stock Down 13% Today?April 5, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLITApril 1, 2024 | investorplace.comNUTX Stock Earnings: Nutex Health Misses Revenue for Q4 2023March 29, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Reports Fourth Quarter And Full Year 2023 Financial ResultsMarch 28, 2024 | finance.yahoo.comNUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSMarch 18, 2024 | investorplace.com3 Promising Penny Stocks You Can Pick Up for Less Than a QuarterMarch 15, 2024 | finanznachrichten.deNutex Health, Inc.: Nutex Health Announces Preliminary 2023 Headline Financials And Provides Update On The Timing Of Its 10-k FilingMarch 15, 2024 | prnewswire.comNUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILINGSee More Headlines Receive NUTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/11/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:NUTX CUSIPN/A CIK1479681 Webwww.nutexhealth.com Phone(713) 660-0557Fax631-670-6780Employees800Year FoundedN/APrice Target and Rating Average Stock Price Target$15.00 High Stock Price Target$15.00 Low Stock Price Target$15.00 Potential Upside/Downside+2,488.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.0595) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,790,000.00 Net Margins-15.85% Pretax Margin-15.77% Return on Equity-44.06% Return on Assets-9.54% Debt Debt-to-Equity Ratio2.99 Current Ratio1.68 Quick Ratio1.63 Sales & Book Value Annual Sales$247.65 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$1.77 per share Price / Book0.33Miscellaneous Outstanding Shares49,720,000Free Float30,567,000Market Cap$28.82 million OptionableNot Optionable Beta0.05 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Thomas T. Vo M.B.A. (Age 51)M.D., Chairman of the Board & CEO Comp: $938.23kDr. Warren Hosseinion M.D. (Age 52)President & Director Comp: $937.66kMr. Jon C. Bates CPA (Age 53)M.B.A., Chief Financial Officer Comp: $299.46kMs. Pamela W. Montgomery B.S.N. (Age 58)J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary Comp: $275.36kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary Comp: $251.33kMr. Joshua DeTillio FACHEM.B.A., Chief Operating OfficerMs. LaChoenda RosalesDirector of AccountingLaTanya BrackensDirector of ComplianceMs. Vivian Sanders M.B.A.Director of MarketingSarah WallaceDirector of Human ResourcesMore ExecutivesKey CompetitorsDHI GroupNYSE:DHXHeritage GlobalNASDAQ:HGBLResearch SolutionsNASDAQ:RSSSMoneyHeroNASDAQ:MNYSteel ConnectNASDAQ:STCNView All CompetitorsInsiders & InstitutionsThomas T VoBought 2,986 shares on 5/30/2024Total: $1,970.76 ($0.66/share)Thomas T VoBought 48,394 shares on 5/28/2024Total: $33,875.80 ($0.70/share)Beaird Harris Wealth Management LLCSold 150,206 shares on 5/15/2024Ownership: 1.569%Thomas T VoBought 17,330 shares on 5/13/2024Total: $11,957.70 ($0.69/share)One Plus One Wealth Management LLCBought 5,043,720 shares on 4/10/2024Ownership: 0.710%View All Insider TransactionsView All Institutional Transactions NUTX Stock Analysis - Frequently Asked Questions Should I buy or sell Nutex Health stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NUTX shares. View NUTX analyst ratings or view top-rated stocks. What is Nutex Health's stock price target for 2024? 1 Wall Street analysts have issued 12-month price objectives for Nutex Health's shares. Their NUTX share price targets range from $15.00 to $15.00. On average, they anticipate the company's share price to reach $15.00 in the next year. This suggests a possible upside of 2,488.0% from the stock's current price. View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts. How have NUTX shares performed in 2024? Nutex Health's stock was trading at $2.70 at the beginning of the year. Since then, NUTX shares have decreased by 78.5% and is now trading at $0.5796. View the best growth stocks for 2024 here. When is Nutex Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our NUTX earnings forecast. How were Nutex Health's earnings last quarter? Nutex Health Inc. (NASDAQ:NUTX) issued its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.01) earnings per share for the quarter. The firm earned $67.45 million during the quarter. Nutex Health had a negative trailing twelve-month return on equity of 44.06% and a negative net margin of 15.85%. When did Nutex Health's stock split? Nutex Health's stock reverse split on the morning of Wednesday, April 10th 2024. The 1-15 reverse split was announced on Wednesday, April 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Nutex Health's major shareholders? Nutex Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include One Plus One Wealth Management LLC (0.71%) and Beaird Harris Wealth Management LLC (1.57%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo. View institutional ownership trends. How do I buy shares of Nutex Health? Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUTX) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.